HAYWARD, Calif., May 15, 2023 /PRNewswire/ — Avirmax CMC Inc. (ACI), a spin off entity of Avirmax Inc., inaugurated state-of-the-art clinical good manufacturing practice (GMP), adeno-associated virus vector (AAV) CDMO facility on May 11th in the presence of ~100 industry experts,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.